血栓管理设备 - 全球市场考量、竞争格局、市场预测 (2030)

全球血栓管理设备市场规模到2023年将达到17.6亿美元，2030年将达22.9亿美元，预计2024-2030年期间复合年增长率为4.50%。 对血栓管理设备的需求主要是由于老年人口的增加（他们构成了血栓形成风险的大部分人口）以及与生活方式相关的疾病（例如高血压和肥胖）的患病率不断增加，从而显着增加了血栓形成的可能性产品开发创新推动了第二代血栓清除设备的开发，最终推动了预测期内血栓管理设备市场的整体成长。

血栓管理设备的市场动态

在血栓管理设备市场，由于多种因素，产品需求不断增加。 主要因素之一是人口老化的加剧。 世界卫生组织（WHO）在《健康老化十年（2020-2030）》报告中提供的数据证明了这一点，该报告显示，60岁及以上的人口数量将增加34%，从2019年的10亿增加到2019年的10亿。2030 年。到 2020 年，这一数字将增至 14 亿。 到 2050 年，世界老年人口将增加一倍以上，达到 21 亿。 除上述统计数据外，世界卫生组织发布的一份关于心血管疾病的情况说明书指出，超过五分之四的心血管疾病死亡主要是由于中风和心臟病发作，其中三分之一的死亡人数为70岁以上的人受到影响。 年龄较大和年龄被认为是许多疾病的主要危险因素，并且增加了发生深部静脉血栓（DVT）等血栓的可能性。 DVT 的主要併发症之一是肺栓塞，这对患者来说可能是致命的。 因此，为了避免此类血栓形成的严重后果，需要使用下腔静脉过滤器等血栓管理装置。 因此，老年人口的增加可能会导致 DVT 病例增加，并进一步推动对血栓管理设备的需求，从而促进预测期内血栓管理设备市场的成长。

此外，推动血栓管理设备需求的另一个主要因素是中风发生率的增加。 根据美国心臟协会（2023）提供的数据，2019年全球中风盛行率为1.015亿人，其中缺血性中风7720万人，脑出血2,070万人，蜘蛛膜下腔出血840万人。

此外，高血压等与生活方式相关的疾病的增加也导致中风风险增加。 根据世界卫生组织关于高血压的数据，截至2022年，全球近12.8亿30岁至79岁的成年人患有高血压。 据报导，高血压不仅会损害心肌，还会导致出血性中风，例如短暂性脑缺血发作（TIA）。 高血压被认为会导致大脑动脉狭窄，增加血栓形成的机会。 因此，高血压族群的增加可能导致出血性中风的盛行率升高，而出血性中风通常会使用支架取栓器和抽吸血栓切除术来治疗。 因此，由于上述因素，血栓管理设备市场预计将在预测期内显着成长。

然而，与设备相关的併发症和频繁的产品召回可能会抑制血栓管理设备市场的成长。

由于实施封锁法规作为遏制 COVID-19 传播的必要措施，血栓管理设备市场正在经历暂时的挫折。 封锁的主要影响之一是世界各地生产流程和供应链的中断。 同时，优先考虑与 COVID-19 相关的患者负担的医疗程序也显着减少，这显着减少了产品需求。 然而，随着COVID-19疫苗在全球范围内获得批准和管理以及医疗服务等各个领域的活动开始，血块管理设备市场正处于恢復阶段，为血块管理设备市场创造了有利的成长环境。 。

本报告研究和分析了全球血栓管理设备市场，提供市场规模和预测、驱动因素和挑战、公司和产品概况等。

目录

第1章血栓管理设备市场报告简介

第2章血栓管理设备市场执行摘要

• 调查范围
• 市场概览
• 竞争评估
• 财务基准

第3章监理与专利分析

• 美国
• 欧洲
• 日本
• 中国

第4章血栓管理器材市场主要因素分析

• 推动血栓管理设备市场的因素
  • 心血管疾病盛行率不断上升
  • 糖尿病和高血压等与生活方式相关的疾病盛行率不断上升
  • 老年人口增加
  • 产品开发中的技术创新
• 血栓管理器械市场的限制与挑战
  • 与装置相关的併发症
  • 频繁的产品召回
• 血栓管理设备市场机遇
  • 改善血栓管理设备的产品设计

第5章血栓管理设备市场波特五力分析

第6章COVID-19对血栓管理器材市场的影响分析

第7章血栓管理器材市场布局

• 依产品类型
  • 血栓切除装置
  • 栓塞导管
  • 下腔静脉滤器
  • 压缩带
  • 其他
• 按最终用户
  • 医院
  • 门诊手术中心
  • 居家照护环境
• 按地区
  • 北美
  • 欧洲
  • 亚太地区
  • 其他领域

第 8 章血栓管理设备市场：全球公司份额分析 - 3 至 5 家主要公司

第 9 章血栓管理设备市场的公司与产品概况

• Edward LifeSciences Corporation
• Stryker
• Johnson & Johnson
• Medtronic
• Penumbra
• Microvention Inc
• Terumo Corporation
• Boston Scientific Corporation
• Abbott
• Acandis GmbH
• Perflow Medical Ltd.
• Koninklijke Philips N.V
• phenox GmbH
• AngioDynamics
• ARGON MEDICAL
• BD
• B. Braun Melsungen AG
• Cardinal Health
• Braile Biomedica
• Cook

第10章KOL观看次数

第 11 章专案方法

第 12 章关于 DelveInsight

第 13 章免责声明与联络我们

Clot Management Devices Market By Product Type (Thrombectomy Devices [Catheter-Directed Thrombolysis Devices, Aspiration Devices, And Stent Retrievers], Embelecotomy Catheters, Inferior Vena Cava Filters [Retrieavble And Permanent], Compression Garments, And Others), And By End User (Hospitals, Ambulatory Surgical Centers, And Others), and by geography is estimated to register appreciable CAGR forecast till 2030 owing to increasing prevalence of strokes and embolsim due to rising geriatric population and lifestyle disorders such as hypertension

Global clot management devices market was valued at USD 1.76 billion in 2023, growing at a CAGR of 4.50% during the forecast period from 2024 to 2030 to reach USD 2.29 billion by 2030. The demand for clot management devices is primarily being boosted by increasing geriatric population who form a big part of at-risk population for developing thrombus, rising prevalence of lifestyle disorders such as hypertension and obesity which massively increase the chances of developing blood clots, and the innovation in product development leading to the development of second-generation thrombectomy devices ultimately contributing in the overall growth of the clot management devices market during the forecast period.

Clot Management Devices Market Dynamics:

The clot management devices market is experiencing increasing product demand owing to the variety of factors. One of the important factors is the increase in the elderly population. This is evident from the data provided by the World Health Organization in their Decade of Healthy Ageing (2020-2030) Report, the number of people aged 60 years and older will be 34% higher, increasing from one billion in 2019 to 1.4 billion in 2030. By 2050, the global population of older people will have more than doubled, to 2.1 billion. In addition to the above-mentioned stats, the factsheet on cardiovascular diseases published by the WHO further stated that more than four-fifths of deaths from cardiovascular diseases are primarily due to stroke and heart attack, and one-third of these deaths affect people under the age of 70. Old age or aging is considered as a major risk factor for numerous diseases as well as increasing the chances of developing thrombosis such as deep vein thrombosis (DVT). One of the major complications of DVT is pulmonary embolism, which can be fatal to the patient. Therefore, in order to avoid such serious consequences of thrombosis, a clot management device such as an inferior vena cava filter is used, among other interventions. Therefore, an increase in the elderly population, which may lead to an increase in the cases of DVT and further drive the demand for clot management devices, thereby contributing in the growth of the clot management devices market during the forecast period.

Moreover, another key factor responsible for driving the demand for clot management devices is the increasing incidence of brain strokes. As per the numbers provided by the American Heart Association (2023), the global prevalence of stroke in 2019 was 101.5 million people, whereas that of ischemic stroke was 77.2 million, that of intracerebral hemorrhage was 20.7 million, and that of subarachnoid hemorrhage was 8.4 million.

Furthermore, the rising prevalence of lifestyle disorders such as hypertension is also linked with increased risk of developing brain strokes. According to the data provided by the WHO on hypertension, as of 2022, near about 1.28 billion adults in the age group of 30-79 years across the globe have hypertension. High blood pressure has been reported to cause damage to the heart muscle as well as cause hemorrhagic strokes such as transient ischemic attack (TIA). Hypertension has been thought to cause the narrowing of arteries in the brain and increases the probability of blood clot formation. Therefore, this may indicate that the growing hypertensive population may result in the higher incidents of hemorrhagic strokes which are commonly treated with stent retrievers and aspiration thrombectomy. Therefore, the clot management devices market is slated to register remarkable growth during the forecast period owing to the factors mentioned above.

However, device-related complications and frequent product recalls may restrict the clot management devices market growth.

The clot management devices market has experienced a period of temporary recession as lockdown restrictions have been enforced as a necessary step to curb the spread of COVID-19 infections. One of the major impacts of lockdowns were observed in the disruption of production process and supply chains across the globe. Along with this, the significant decrease in the medical procedures due to prioritizing of COVID-19 infection-associated patient load, there was a striking decrease in the product demand because of that. However, the clot management devices market is in the recovery stage, with numerous COVID-19 vaccines being approved and administered worldwide, and activities have begun in various areas such as medical services thereby presenting a positive growth environment for the clot management devices market.

Clot Management Devices Market Segment Analysis:

Clot Management Devices Market by Product Type (Thrombectomy Devices [Catheter-Directed Thrombolysis Devices, Aspiration Devices, and Stent Retrievers], Embelecotomy Catheters, Inferior Vena cava Filters [Retrievable and Permanent], Compression Garments, and Others), and by End User (Hospitals, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the clot management devices market, the stent retrievers' sub category in the thrombectomy devices category expected to amass a significant share in the market revenue during the forecast period. This can be ascribed to their advantages such as mechanical thrombectomy with stent retrievers is reported to produce superior clinical outcome in acute stroke patients compared to medical therapy alone. In addition to that, stent retrievers have a safety profile similar to that of systemic thrombolytic therapy.

Moreover, improvements in product design such as the incorporation of platinum for improved visibility (Trevo Provue and Solitaire Platinum) and longer lengths up to 40 mm have helped in improving the first-pass reperfusion outcomes. The entry of revoerable self-expanding thrombectomy devices further offer advantages such as he devices restore flow immediately and avoid the placement of a permanent stent, immediate restoration of blood and the eliminating the need for the placement of a permanent stent thereby reducing the chances of in-stent restenosis. Thus the factors mentioned above are expected to drive the demand for this product category, ultimately driving the clot management devices market forward.

North America is expected to dominate the overall Clot Management Devices Market:

Among all the regions, North America is estimated to account for the largest share in the clot management devices market. Owing to significance of key growth factors such as rising prevalence of DVT, embolism due to the increasing prevalence of obesity, hypertension and diabetes, the aging population, growing prevalence of cancers, and rising government initiatives regarding disease treatment awareness, the North America clot management devices market is expected to witness positive growth. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and high awareness also helped the market growth in this region.

One of the key reasons positively influencing the growth of the United States clot management devices market is the rising prevalence of cancers in the US population. As per the latest data provided by American Cancer Society, around 1.9 million new cancer cases were diagnosed and 608,570 cancer deaths were reported in the United States in 2022. Cancer patients are thought to have specific abnormal coagulation factors which increase the chances of thrombus formation. Additionally, chemotherapy is also related with the increased risk of venous thrombosis resulting in deep vein thrombosis. Therefore, the rising prevalence of cancers in the country is expected to aid in the growing need for thrombus management devices thereby resulting in increase in product demand aiding in the growth of the United States clot management devices market.

Moreover, the rising prevalence of lifestyle disorders such as obesity is also considered as a key factor in the growing number of cases of clot formation in diseases such as DVT, brain strokes, and embolism. As per the data provided by the Canadian government (2023), in 2019, based on the body-mass index, approximately 56.5% of the Canadian population across all age groups was obese. Obesity is one of the most common factors that may result in embolism or DVT. Furthermore, obesity is also related with the inefficacy of anticoagulation therapeutics in obese patients. This further acts in the favor of thrombectomy and clot management devices. Therefore, the presence of large patient population suffering from obesity correlates to the presence of a high patient population suffering from as strokes, embolism, and DVT which would indicate the growing need for clot management equipment, thereby resulting in increase in product demand supporting the growth of the North America clot management devices market during the forecast period.

Clot Management Devices Market Key Players:

Some of the key market players operating in the clot management devices market includes Edward LifeSciences Corporation, Stryker, Johnson & Johnson, Medtronic, Penumbra, Microvention Inc., Terumo Corporation, Boston Scientific Inc, Abbott, Acandis GmbH, Perflow Medical Ltd, Koninklijke Philips N.V., phenox GmbH, AngioDynamics, ARGON MEDICAL, BD, B. Braun Melsungen AG, Cardinal Health., Braile Biomedica, Cook and others.

Recent Developmental Activities in Clot Management Devices Market:

In August 2022, Stryker Neurovascular received the regulatory approval from the US Food and Drug Administration (USFDA) for their Trevo NXT Pro Vue Retiever, a class II medical device classified as a neurovascular mechanical thrombectomy device for acute ischemic stroke.

In September 2022, Abbott announced the acquisition of Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots.

In February 2022, Inari Medical received the 510k approval for their Triever embelectomy catheters by the US FDA.

Key Takeaways from the Clot Management Devices Market Report Study

Market size analysis for clot management devices market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the clot management devices market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Clot Management Devices Market.

Various opportunities available for the other competitor in the Clot Management Devices Market space.

What are the top performing segments in 2023? How these segments will perform in 2030.

Which is the top-performing regions and countries in the current clot management devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for clot management devices market growth in the coming future?

Target Audience Who Can Be Benefited From This Clot Management Devices Market Report Study

Clot Management Devices products providers

Research organizations and consulting companies

Clot Management Devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in clot management devices

Various End-users who want to know more about the Clot Management Devices market and latest technological developments in the Clot Management Devices market.

Frequently Asked Questions for Clot Management Devices Market:

1. What are Clot Management Devices?

Clot management devices are medical devices that are employed in the removal blood clots from peripheral as well as neurovasculature.

2. What is the market for Global Clot Management Devices?

Global clot management devices market was valued at USD 1.76 billion in 2023, growing at a CAGR of 4.50% during the forecast period from 2024 to 2030 to reach USD 2.29 billion by 2030.

3. What are the drivers for Global Clot Management Devices Market?

The demand for clot management devices is primarily being boosted by increasing geriatric population who form a big part of at-risk population for developing thromboses, rising prevalence of lifestyle disorders such as hypertension and obesity which massively increase the chances of developing blood clots, and the innovation in product development leading to the development of second-generation thrombectomy devices ultimately contributing in the overall growth of the clot management devices market during the forecast period.

4. Who are the key players operating in Global Clot Management Devices Market?

Some of the key market players operating in the clot management devices market includes Edward LifeSciences Corporation, Stryker, Johnson & Johnson, Medtronic, Penumbra, Microvention Inc., Terumo Corporation, Boston Scientific Inc, Abbott, Acandis GmbH, Perflow Medical Ltd, Koninklijke Philips N.V., phenox GmbH, AngioDynamics, ARGON MEDICAL, BD, B. Braun Melsungen AG, Cardinal Health., Braile Biomedica, Cook and others.

5. Which region has the highest share in Clot Management Devices market?

North America is expected to dominate the overall Clot Management Devices market during the forecast period. Owing to significance of key growth factors such as rising prevalence of DVT, embolism due to the increasing prevalence of obesity, hypertension and diabetes, the aging population, growing prevalence of cancers, and rising government initiatives regarding disease treatment awareness, the North America clot management devices market is expected to witness positive growth. Furthermore, high disposable income, sophisticated healthcare infrastructure, new product approvals, and high awareness also helped the market growth in this region.

Table of Contents

1.Clot Management Devices Market Report Introduction

2.Clot Management Devices Market Executive Summary

• 2.1 Scope of the Study
• 2.2 Market at Glance
• 2.3 Competitive Assessment
• 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

• 3.1 The United States
• 3.2 Europe
• 3.3 Japan
• 3.4 China

4. Clot Management Devices Market Key Factors Analysis

• 4.1 Clot Management Devices Market Drivers
  • 4.1.1 Rising Prevalence of Cardiovascular Diseases
  • 4.1.2 Increasing Prevalence of Lifestyle Disorders such as Diabetes and Hypertension
  • 4.1.3 Increasing Geriatric Population
  • 4.1.4 Technical Innovation in Product Development
• 4.2 Clot Management Devices Market Restraints and Challenges
  • 4.2.1 Device-Related Complications
  • 4.2.2 Frequent Product Recalls
• 4.3 Clot Management Devices Market Opportunities
  • 4.3.1 Improving Product Design of Clot Management Devices

5. Clot Management Devices Market Porter's Five Forces Analysis

• 5.1 Bargaining Power of Suppliers
• 5.2 Bargaining Power of Consumers
• 5.3 Threat of New Entrants
• 5.4 Threat of Substitutes
• 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Clot Management Devices Market

7. Clot Management Devices Market Layout

• 7.1 By Product Type
  • 7.1.1 Thrombectomy Devices
    • 7.1.1.1 Catheter-Directed Thrombolysis Devices
    • 7.1.1.2 Aspiration Devices
    • 7.1.1.3 Stent Retrievers
  • 7.1.2 Embelectomy Catheters
  • 7.1.3 Inferior Vena Cava Filters
    • 7.1.3.1 Retrievable
    • 7.1.3.2 Permanent
  • 7.1.2 Compression Garments
  • 7.1.2 Others
• 7.2 By End User
  • 7.2.1 Hospitals
  • 7.2.2 Ambulatory Surgical Centers
  • 7.2.3 Homecare Settings
  • 7.2.4 Others
• 7.3. By Geography
  • 7.3.1 North America
    • 7.3.1.1 North America Clot Management Devices Market, by Product Type
    • 7.3.1.2 North America Clot Management Devices Market, by End User
    • 7.3.1.3 North America Clot Management Devices Market, by Country
    • 7.3.1.3.1 United States
    • 7.3.1.3.2 Canada
    • 7.3.1.3.3 Mexico
  • 7.3.2 Europe
    • 7.3.2.1 Europe Clot Management Devices Market, by Product Type
    • 7.3.2.2 Europe Clot Management Devices Market, by End User
    • 7.3.2.3 Europe Clot Management Devices Market, by Country
    • 7.3.2.3.1 France
    • 7.3.2.3.2 Germany
    • 7.3.2.3.3 United Kingdom
    • 7.3.2.3.4 Italy
    • 7.3.2.3.5 Spain
    • 7.3.2.3.6 Russia
    • 7.3.2.3.7 Rest of Europe
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Asia-Pacific Clot Management Devices Market, by Product Type
    • 7.3.3.2 Asia-Pacific Clot Management Devices Market, by End User
    • 7.3.3.3 Asia-Pacific Clot Management Devices Market, by Country
    • 7.3.3.3.1 China
    • 7.3.3.3.2 Japan
    • 7.3.3.3.3 India
    • 7.3.3.3.4 Australia
    • 7.3.3.3.5 South Korea
    • 7.3.3.3.6 Rest of Asia Pacific
  • 7.3.4 Rest of the World (RoW)
    • 7.3.4.1 RoW Clot Management Devices Market, by Product Type
    • 7.3.4.2 RoW Clot Management Devices Market, by End User
    • 7.3.4.3 RoW Clot Management Devices Market, by Region
    • 7.3.4.3.1 Middle East
    • 7.3.4.3.2 Africa
    • 7.3.4.3.3 South America

8. Clot Management Devices Market Global Company Share Analysis - Key 3-5 Companies

9. Clot Management Devices Market Company and Product Profiles

• 9.1 Edward LifeSciences Corporation
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4 Product Listing
  • 9.1.5. Entropy
• 9.2 Stryker
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4 Product Listing
  • 9.2.5. Entropy
• 9.3 Johnson & Johnson
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4 Product Listing
  • 9.3.5. Entropy
• 9.4 Medtronic
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4 Product Listing
  • 9.4.5. Entropy
• 9.5 Penumbra
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4 Product Listing
  • 9.5.5. Entropy
• 9.6 Microvention Inc
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4 Product Listing
  • 9.6.5. Entropy
• 9.7 Terumo Corporation
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4 Product Listing
  • 9.7.5. Entropy
• 9.8 Boston Scientific Corporation
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4 Product Listing
  • 9.8.5. Entropy
• 9.9 Abbott
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4 Product Listing
  • 9.9.5. Entropy
• 9.10 Acandis GmbH
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4 Product Listing
  • 9.10.5. Entropy
• 9.11 Perflow Medical Ltd.
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4 Product Listing
  • 9.11.5. Entropy
• 9.12 Koninklijke Philips N.V
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4 Product Listing
  • 9.12.5. Entropy
• 9.13 phenox GmbH
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4 Product Listing
  • 9.13.5. Entropy
• 9.14 AngioDynamics
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4 Product Listing
  • 9.14.5. Entropy
• 9.15 ARGON MEDICAL
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4 Product Listing
  • 9.15.5. Entropy
• 9.16 BD
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4 Product Listing
  • 9.16.5. Entropy
• 9.17 B. Braun Melsungen AG
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4 Product Listing
  • 9.17.5. Entropy
• 9.18 Cardinal Health
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4 Product Listing
  • 9.18.5. Entropy
• 9.19 Braile Biomedica
  • 9.19.1. Company Overview
  • 9.19.2. Company Snapshot
  • 9.19.3. Financial Overview
  • 9.19.4 Product Listing
  • 9.19.5. Entropy
• 9.20 Cook
  • 9.20.1. Company Overview
  • 9.20.2. Company Snapshot
  • 9.20.3. Financial Overview
  • 9.20.4 Product Listing
  • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

• Table 1 Competitive Analysis
• Table 2 COVID-19 Impact Analysis
• Table 3 Clot Management Devices Market in Global (2021-2030)
• Table 4 Clot Management Devices Market in Global by Product Type (2021-2030)
• Table 5 Clot Management Devices Market in Global by End User (2021-2030)
• Table 6 Clot Management Devices Market in Global by Geography (2021-2030)
• Table 7 Clot Management Devices Market in North America (2021-2030)
• Table 8 Clot Management Devices Market in North America by Product Type (2021-2030)
• Table 9 Clot Management Devices Market in North America by End User (2021-2030)
• Table 10 Clot Management Devices Market in North America by Country (2021-2030)
• Table 11 Clot Management Devices Market in the US (2021-2030)
• Table 12 Clot Management Devices Market in Canada (2021-2030)
• Table 13 Clot Management Devices Market in Mexico (2021-2030)
• Table 14 Clot Management Devices Market in Europe (2021-2030)
• Table 15 Clot Management Devices Market in Europe by Product Type (2021-2030)
• Table 16 Clot Management Devices Market in Europe by End User (2021-2030)
• Table 17 Clot Management Devices Market in Europe by Country (2021-2030)
• Table 18 Clot Management Devices Market in France (2021-2030)
• Table 19 Clot Management Devices Market in Germany (2021-2030)
• Table 20 Clot Management Devices Market in the United Kingdom (2021-2030)
• Table 21 Clot Management Devices Market in Italy (2021-2030)
• Table 22 Clot Management Devices Market in Spain (2021-2030)
• Table 23 Clot Management Devices Market in Russia (2021-2030)
• Table 24 Clot Management Devices Market in Rest of Europe (2021-2030)
• Table 25 Clot Management Devices Market in APAC (2021-2030)
• Table 26 Clot Management Devices Market in APAC by Product Type (2021-2030)
• Table 27 Clot Management Devices Market in APAC by End User (2021-2030)
• Table 28 Clot Management Devices Market in APAC by Country (2021-2030)
• Table 29 Clot Management Devices Market in China (2021-2030)
• Table 30 Clot Management Devices Market in Japan (2021-2030)
• Table 31 Clot Management Devices Market in India (2021-2030)
• Table 32 Clot Management Devices Market in Australia (2021-2030)
• Table 33 Clot Management Devices Market in South Korea (2021-2030)
• Table 34 Clot Management Devices Market in Rest of APAC (2021-2030)
• Table 35 Clot Management Devices Market in Rest of World (2021-2030)
• Table 36 Clot Management Devices Market in RoW by Product Type (2021-2030)
• Table 37 Clot Management Devices Market in RoW by End User (2021-2030)
• Table 38 Clot Management Devices Market in RoW by Region (2021-2030)
• Table 39 Clot Management Devices Market in Middle East (2021-2030)
• Table 40 Clot Management Devices Market in Africa (2021-2030)
• Table 41 Clot Management Devices Market in South America (2021-2030)

List of Figures

• Figure 1 Competitive Analysis
• Figure 2 COVID-19 Impact Analysis
• Figure 3 Clot Management Devices Market in Global (2021-2030)
• Figure 4 Clot Management Devices Market in Global by Product Type (2021-2030)
• Figure 5 Clot Management Devices Market in Global by End User (2021-2030)
• Figure 6 Clot Management Devices Market in Global by Geography (2021-2030)
• Figure 7 Clot Management Devices Market in North America (2021-2030)
• Figure 8 Clot Management Devices Market in North America by Product Type (2021-2030)
• Figure 9 Clot Management Devices Market in North America by End User (2021-2030)
• Figure 10 Clot Management Devices Market in North America by Country (2021-2030)
• Figure 11 Clot Management Devices Market in the US (2021-2030)
• Figure 12 Clot Management Devices Market in Canada (2021-2030)
• Figure 13 Clot Management Devices Market in Mexico (2021-2030)
• Figure 14 Clot Management Devices Market in Europe (2021-2030)
• Figure 15 Clot Management Devices Market in Europe by Product Type (2021-2030)
• Figure 16 Clot Management Devices Market in Europe by End User (2021-2030)
• Figure 17 Clot Management Devices Market in Europe by Country (2021-2030)
• Figure 18 Clot Management Devices Market in France (2021-2030)
• Figure 19 Clot Management Devices Market in Germany (2021-2030)
• Figure 20 Clot Management Devices Market in the United Kingdom (2021-2030)
• Figure 21 Clot Management Devices Market in Italy (2021-2030)
• Figure 22 Clot Management Devices Market in Spain (2021-2030)
• Figure 23 Clot Management Devices Market in Russia (2021-2030)
• Figure 24 Clot Management Devices Market in Rest of Europe (2021-2030)
• Figure 25 Clot Management Devices Market in APAC (2021-2030)
• Figure 26 Clot Management Devices Market in APAC by Product Type (2021-2030)
• Figure 27 Clot Management Devices Market in APAC by End User (2021-2030)
• Figure 28 Clot Management Devices Market in APAC by Country (2021-2030)
• Figure 29 Clot Management Devices Market in China (2021-2030)
• Figure 30 Clot Management Devices Market in Japan (2021-2030)
• Figure 31 Clot Management Devices Market in India (2021-2030)
• Figure 32 Clot Management Devices Market in Australia (2021-2030)
• Figure 33 Clot Management Devices Market in South Korea (2021-2030)
• Figure 34 Clot Management Devices Market in Rest of APAC (2021-2030)
• Figure 35 Clot Management Devices Market in Rest of World (2021-2030)
• Figure 36 Clot Management Devices Market in RoW by Product Type (2021-2030)
• Figure 37 Clot Management Devices Market in RoW by End User (2021-2030)
• Figure 38 Clot Management Devices Market in RoW by Region (2021-2030)
• Figure 39 Clot Management Devices Market in Middle East (2021-2030)
• Figure 40 Clot Management Devices Market in Africa (2021-2030)
• Figure 41 Clot Management Devices Market in South America (2021-2030)
• Figure 42 Market Drivers
• Figure 43 Market Barriers
• Figure 44 Marker Opportunities
• Figure 45 PORTER'S Five Force Analysis